Regeneron and Bayer settle appeal over launch of Eylea biosimilar

MELBOURNE: Biotech Regeneron and drug company Bayer have resolved their appeal of a ... read more

PEE amongst the last buyers still standing at Aidacare

SYDNEY: One private equity firm has pulled to the front of the pack ... read more

F&P Healthcare maps out plan for mega-campus to house 18,000 staff

AUCKLAND: Fisher & Paykel Healthcare, has mapped out plans for a massive new ... read more

US pharma ramps up attack on ‘discriminatory’ drug pricing

MELBOURNE: The US pharmaceutical industry is increasing pressure on Donald Trump to take ... read more